Hacker News new | past | comments | ask | show | jobs | submit login

  The drug maker K-V Pharmaceutical obtained exclusive 
  rights to produce an injection for women at high risk of 
  delivering prematurely. But the FDA is opening up the 
  market to specialty pharmacies after the company raised 
  the dosage price from $20 to $1,500.
http://www.latimes.com/health/la-na-fda-drug-price-20110331,...



Hopefully they will do the same for colchicine! So far, no cigar though and we(colchicine consumers) have a pretty active community that's been trying for years now to prevent this from happening with little luck.


It's not the same. The previous "drug" was really just mixing two existing drugs together. The company hoped they could legally prevent people from mixing those drugs. But the individual unmixed drugs are widely available. The FDA said they would not prevent people from mixing (compounding) drugs.

In this case it's drug on it's own. I.e. manufactured. And for this they do actually have the legal right to be the only ones making it.




Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: